Broadleaf Capital Partners, Inc. To Acquire Sustained Release, Inc.

Posted in the Virginia Beach Forum

Since: Sep 13

Las Vegas, NV

#1 Oct 30, 2013
(CRWE Press Release)– Broadleaf Capital Partners, Inc.(OTC:BDLF) and Sustained Release, Inc.(SRI) have agreed to terms and conditions under which Broadleaf will acquire Sustained Release, Inc. The agreement is scheduled to become effective on or before December 1, 2013.

Mike King, President of Broadleaf, stated:“This acquisition is exciting because Sustained Release brings to us a contract with Akina, Inc. relating to extended drug delivery systems. This patent protected technology will provide much needed dynamic benefits to the pharmaceutical sector and will also dramatically improve our shareholder value.”

Akina, Inc. is a research and development company known for developing unique methods for delivering medications. It was founded in 2001 by Kinam Park, Showalter Distinguished Professor of Biomedical Engineering and Professor of Pharmaceutics at Purdue University.

Akina Is a pioneer in the development of the long-term release micro particle formulations, also referenced as “Sustained Release Formulations”, which have release durations ranging from one to eight months, and are -designed to replace repeated daily, weekly or monthly administration of drugs for long-term care of diseases and disorders, thereby higher efficacy of the drug.

The Akina micro particles are programmable in release kinetics and ideal for release of active pharmaceutical ingredients for terms ranging from a few weeks to several months. They are inexpensive to produce, readily scalable for mass production, and offer a wide range of clinical applications.

Examples of current micro particle formulations under development at Akina address specific conditions such as macular degeneration, glaucoma, periodontal disease, and inflammation. Akina’s hydrogel template method is highly unique in that the process does not include oil/water emulsion, and thus it allows controlled manipulation of the drug/polymer formulation which has not been possible by other methods.

About Broadleaf Capital Partners:

Broadleaf Capital Partners Inc. Inc.(OTC:BDLF) actively identifies and reviews unique and proprietary technologies for investment consideration. Broadleaf seeks such technologies held by emerging or early stage, small to medium-size companies in various fields of business to arrange for capital and provide management support. Our goal is to provide our stockholders capital appreciation and a solid dividend yield.

Full press release at http://crwepressrelease.com/1359/news-by-cate...

Tell me when this thread is updated:

Subscribe Now Add to my Tracker

Add your comments below

Characters left: 4000

Please note by submitting this form you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.

Virginia Beach Discussions

Title Updated Last By Comments
News Barack Obama, our next President (Nov '08) 3 min RoxLo 1,224,540
News Once slow-moving threat, global warming speeds ... (Dec '08) 3 hr Patriot AKA Bozo 53,054
News 1 dead, 1 wounded in Portsmouth shooting (May '10) 3 hr Kfields 15
Gay meet up (Aug '14) May 3 Bibro2369 10
colette draeger May 2 RANSOM PRIDE 1
looking for james Aaron burgess (Oct '14) Apr 30 Nadja93 4
News Sailor arrested on child pornography production... (Apr '10) Apr 30 misty 3
More from around the web

Virginia Beach People Search

Addresses and phone numbers for FREE

Personal Finance

Mortgages [ See current mortgage rates ]